Inflammation, demyelination, and degeneration — Recent insights from MS pathology

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S., & Hinson, S. R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050304 · Cited by 2,288

The spectrum of neuromyelitis optica

Wingerchuk, D. M., Lennon, V. A., Lucchinetti, C. F., Pittock, S. J., & Weinshenker, B. G. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70216-8 · Cited by 2,182

Cortical demyelination and diffuse white matter injury in multiple sclerosis

Kutzelnigg, A., Lucchinetti, C. F., Stadelmann, C., Brück, W., Rauschka, H., Bergmann, M., Schmidbauer, M., Parisi, J. E., & Lassmann, H. (2005) · Brain · doi:10.1093/brain/awh641 · Cited by 1,836

Multiple sclerosis--the plaque and its pathogenesis.

Frohman, E., Racke, M., & Raine, C. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052130 · Cited by 1,793

Axonal damage in acute multiple sclerosis lesions

Ferguson, B. (1997) · Brain · doi:10.1093/brain/120.3.393 · Cited by 1,532

Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology

Magliozzi, R., Howell, O. W., Vora, A., Serafini, B., Nicholas, R. S., Puopolo, M., Reynolds, R., & Aloisi, F. (2006) · Brain · doi:10.1093/brain/awm038 · Cited by 1,486

The relation between inflammation and neurodegeneration in multiple sclerosis brains

Frischer, J. M., Bramow, S., Dal-Bianco, A., Lucchinetti, C. F., Rauschka, H., Schmidbauer, M., Laursen, H., Sorensen, P. S., & Lassmann, H. (2009) · Brain · doi:10.1093/brain/awp070 · Cited by 1,450

Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions

Peterson, J. W., Bö, L., Mörk, S., Chang, A., & Trapp, B. D. (2001) · Annals of Neurology · doi:10.1002/ana.1123 · Cited by 1,403

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.

Lucchinetti, C., Mandler, R., McGavern, D., Brück, W., Gleich, G., Ransohoff, R., Trebst, C., Weinshenker, B., Wingerchuk, D., Parisi, J., et al. (2002) · Brain : a journal of neurology · doi:10.1093/brain/awf151 · Cited by 1,228

Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion

Barnett, M. H., & Prineas, J. W. (2004) · Annals of Neurology · doi:10.1002/ana.20016 · Cited by 1,184

Glatiramer acetate attenuates the pro-migratory profile of adhesion molecules on various immune cell subsets in multiple sclerosis

Sellner, J., Koczi, W., Harrer, A., Oppermann, K., Obregon-Castrillo, E., Pilz, G., Wipfler, P., Afazel, S., Haschke‐Becher, E., Trinka, E., et al. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12125 · Cited by 30

Indirect Effects of Racial Discrimination on Health Outcomes Through Prefrontal Cortical White Matter Integrity

Okeke, O., Elbasheir, A., Carter, S. E., Powers, A. D., Mekawi, Y., Gillespie, C. F., Schwartz, A. C., Bradley, B., & Fani, N. (2022) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2022.05.004 · Cited by 32

St. John’s wort and its component hyperforin alleviate experimental autoimmune encephalomyelitis through expansion of regulatory T-cells

Nosratabadi, R., Rastin, M., Sankian, M., Haghmorad, D., Tabasi, N. S., Zamani, S., Aghaee, A., Salehipour, Z., & Mahmoudi, M. (2015) · Journal of Immunotoxicology · doi:10.3109/1547691x.2015.1101512 · Cited by 29

Transglutaminases in Monocytes and Macrophages

Sun, H., & Kaartinen, M. T. (2018) · Medical Sciences · doi:10.3390/medsci6040115 · Cited by 32

Antibody patterns vary arbitrarily between cerebrospinal fluid and aqueous humor of the individual multiple sclerosis patient: Specificity-independent pathological B cell function

Reiber, H., Kruse-Sauter, H., & Quentin, C. D. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.11.013 · Cited by 26

Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis

Hojjat, S., Kincal, M., Vitorino, R., Cantrell, C. G., Feinstein, A., Zhang, L., Lee, L., O'Connor, P. W., Carroll, T., & Aviv, R. I. (2016) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4737 · Cited by 28

Blood Mononuclear Cell Mitochondrial Respiratory Chain Complex IV Activity is Decreased in Multiple Sclerosis Patients: Effects of β-Interferon Treatment

Hargreaves, I. P., Mody, N., Land, J. M., & Heales, S. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7020036 · Cited by 26

Patterns of Cognitive Dysfunction in Progressive MS

Connick, P., Chandran, S., & Bak, T. H. (2013) · Behavioural Neurology · doi:10.1155/2013/743878 · Cited by 26

Repurposing of Secukinumab as Neuroprotective in Cuprizone-Induced Multiple Sclerosis Experimental Model via Inhibition of Oxidative, Inflammatory, and Neurodegenerative Signaling

Abdel-Maged, A. E.-S., Gad, A. M., Rashed, L. A., Azab, S. S., Mohamed, E. A., & Awad, A. S. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01972-9 · Cited by 29

Oligodendrocyte‐specific deletion of FGFR2 ameliorates MOG35‐55‐induced EAE through ERK and Akt signalling

Kamali, S., Rajendran, R., Stadelmann, C., Karnati, S., Rajendran, V., Giraldo‐Velásquez, M., & Berghoff, M. (2020) · Brain Pathology · doi:10.1111/bpa.12916 · Cited by 26

Multiple Sclerosis

Yamasaki, R., & Kira, J. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9636-7_14 · Cited by 25

Exosome Content–Mediated Signaling Pathways in Multiple Sclerosis

Mohammadinasr, M., Montazersaheb, S., Ayromlou, H., Hosseini, V., Molavi, O., & Hejazi, M. S. (2024) · Molecular Neurobiology · doi:10.1007/s12035-023-03862-2 · Cited by 28

Arterial, venous and other vascular risk factors in multiple sclerosis

Karmon, Y., Ramanathan, M. K., Minagar, A., Zivadinov, R., & Weinstock‐Guttman, B. (2012) · Neurological Research · doi:10.1179/1743132812y.0000000077 · Cited by 25

Protective Effects of the Caffeine Against Neurodegenerative Diseases

Tellone, E., Galtieri, A., Russo, A., & Ficarra, S. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666171009104040 · Cited by 25

Biomechanically‐Adapted Immunohydrogels Reconstructing Myelin Sheath for Peripheral Nerve Regeneration

Wang, Y., Yan, Z., Liu, W., Liu, C., Xu, N., Wu, Y., Sun, F., Wang, X., Qian, Y., Jiang, L., et al. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202201596 · Cited by 24

A cell-mimicking platelet-based drug delivery system as a potential carrier of dimethyl fumarate for multiple sclerosis

Mehdi-Alamdarlou, S., Ahmadi, F., Azadi, A., Shahbazi, M., Heidari, R., & Ashrafi, H. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122084 · Cited by 24

Interleukin 2 receptor α chain gene polymorphisms and risks of multiple sclerosis and neuromyelitis optica in southern Japanese

Ainiding, G., Kawano, Y., Sato, S., Isobe, N., Matsushita, T., Yoshimura, S., Yonekawa, T., Yamasaki, R., Murai, H., & Kira, J. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.11.037 · Cited by 24

Patterns of cognitive dysfunction in progressive MS.

Connick, P., Chandran, S., & Bak, T. H. (2013) · Europe PMC (PubMed Central) · doi:10.3233/ben-120286 · Cited by 25

Engineering biomaterial microenvironments to promote myelination in the central nervous system

Unal, D. B., Caliari, S. R., & Lampe, K. J. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.07.013 · Cited by 24

Erratum to: Matrine Treatment Blocks NogoA-Induced Neural Inhibitory Signaling Pathway in Ongoing Experimental Autoimmune Encephalomyelitis

Kan, Q., Zhang, H.-J., Zhang, Y., Li, X., Xu, Y., Thomé, R., Zhang, M., Liu, N., Chu, Y., Zhang, G., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0410-0 · Cited by 24

The therapeutic potential of ginkgolide K in experimental autoimmune encephalomyelitis via peripheral immunomodulation

Yu, W.-B., Wang, Q., Chen, S., Cao, L., Tang, J., Ma, C.-G., Xiao, W., & Xiao, B.-G. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.02.035 · Cited by 20

The Potential Contribution of Dysfunctional RNA-Binding Proteins to the Pathogenesis of Neurodegeneration in Multiple Sclerosis and Relevant Models

Libner, C. D., Salapa, H. E., & Levin, M. C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134571 · Cited by 24

Progress and Promise of Nur77-based Therapeutics for Central Nervous System Disorders

Liu, L., Ma, D., Zhuo, L., Pang, X., You, J., & Feng, J. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200606231723 · Cited by 21

Neuroantigen-specific, tolerogenic vaccines: GM-CSF is a fusion partner that facilitates tolerance rather than immunity to dominant self-epitopes of myelin in murine models of experimental autoimmune encephalomyelitis (EAE)

Abbott, D. J., Blanchfield, L., Martinson, D. A., Russell, S. C., Taslim, N., Curtis, A. D., & Mannie, M. D. (2011) · BMC Immunology · doi:10.1186/1471-2172-12-72 · Cited by 22

Laquinimod prevents cuprizone-induced demyelination independent of Toll-like receptor signaling

Kramann, N., Menken, L., Hayardeny, L., Hanisch, U., & Brück, W. (2016) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000233 · Cited by 22

Quantitative analysis of lipid debris accumulation caused by cuprizone induced myelin degradation in different CNS areas

Ozsvár, A., Szipöcs, R., Ozsvár, Z., Baka, J., Barzó, P., Tamás, G., & Molnár, G. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.01.003 · Cited by 24

Novel cell-based analysis reveals region-dependent changes in microglial dynamics in grey matter in a cuprizone model of demyelination

Roufagalas, I., Avloniti, M., Fortosi, A., Xingi, E., Thomaidou, D., Probert, L., & Kyrargyri, V. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105449 · Cited by 23

NR4A1 agonist cytosporone B attenuates neuroinflammation in a mouse model of multiple sclerosis

Wang, L., Yu, H.-Z., Zhu, B.-Q., Zhu, L. D., & Li, S. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.339492 · Cited by 22

Long‐term impact of neonatal inflammation on demyelination and remyelination in the central nervous system

Bénardais, K., Gudi, V., Gai, L., Nessler, J. N., Singh, V., Prajeeth, C. K., Skripuletz, T., & Stangel, M. (2014) · Glia · doi:10.1002/glia.22706 · Cited by 19

Temelimab, an IgG4 Anti-Human Endogenous Retrovirus Monoclonal Antibody: An Early Development Safety Review

Kornmann, G., & Curtin, F. (2020) · Drug Safety · doi:10.1007/s40264-020-00988-3 · Cited by 20

Cladribine tablets’ potential role as a key example of selective immune reconstitution therapy in multiple sclerosis

Boyко, A., & Boyko, O. V. (2018) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s161450 · Cited by 21

The role of myelin in neurodegeneration: implications for drug targets and neuroprotection strategies

Parrilla, G. E., Gupta, V., Wall, R. V., Salkar, A., Basavarajappa, D. K., Mirzaei, M., Chitranshi, N., Graham, S. L., & You, Y. (2023) · Reviews in the Neurosciences · doi:10.1515/revneuro-2023-0081 · Cited by 22

Capillary isoelectric focusing immunoassay as a new nanoscale approach for the detection of oligoclonal bands

Halbgebauer, S., Haußmann, U., Klafki, H., Tumani, H., Wiltfang, J., & Otto, M. (2014) · Electrophoresis · doi:10.1002/elps.201400339 · Cited by 18

Diffusion imaging of fornix and interconnected limbic deep grey matter is linked to cognitive impairment in multiple sclerosis

Cabrera, D. V., Smyth, P. S., Blevins, G., Emery, D. J., & Beaulieu, C. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15539 · Cited by 18

A review of the auditory-gut-brain axis

Graham, A. S., Ben‐Azu, B., Tremblay, M., Torre, P., Senekal, M., Laughton, B., van der Kouwe, A. J. W., Jankiewicz, M., Kaba, M., & Holmes, M. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1183694 · Cited by 22

Application of quantitative proteomics technologies to the biomarker discovery pipeline for multiple sclerosis

Dagley, L. F., Emili, A., & Purcell, A. W. (2012) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201200104 · Cited by 19

Assessment of neuroactive steroids in cerebrospinal fluid comparing acute relapse and stable disease in relapsing-remitting multiple sclerosis

Orefice, N. S., Carotenuto, A., Mangone, G., Bues, B., Rehm, R., Cerillo, I., Saccà, F., Calignano, A., & Orefice, G. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.02.012 · Cited by 19

Alterations in serum levels of IL-17 in contrast to TNF-alpha correspond to disease-modifying treatment in relapsing-remitting multiple sclerosis

Trenova, A. G., Slavov, G. S., Manova, M. G., Draganova-Filipova, M., Mateva, N. G., Miteva, L. D., & Stanilova, S. A. (2017) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2017.1303843 · Cited by 18

Mechanism of action of s1p receptor modulators in multiple sclerosis: The double requirement

Bordet, R., Camu, W., Seze, J. D., Laplaud, D. A., Ouallet, J., & Thouvenot, É. (2019) · Revue Neurologique · doi:10.1016/j.neurol.2019.02.007 · Cited by 19

Allelic Combinations of Immune-Response Genes as Possible Composite Markers of IFN-β Efficacy in Multiple Sclerosis Patients

Кулакова, О. Г., Tsareva, E., Boyко, A., Shchur, S. G., Gusev, E. I., Lvovs, D., Favorov, A. V., Vandenbroeck, K., & Favorova, O. O. (2012) · Pharmacogenomics · doi:10.2217/pgs.12.161 · Cited by 17

Neuroprotective natural products against experimental autoimmune encephalomyelitis: A review

Mohtashami, L., Shakeri, A., & Javadi, B. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104516 · Cited by 17

Inhibition of SLPI ameliorates disease activity in experimental autoimmune encephalomyelitis

Müller, A. M., Jun, E., Conlon, H., & Sadiq, S. A. (2012) · BMC Neuroscience · doi:10.1186/1471-2202-13-30 · Cited by 16

Detection of intrathecal immunoglobulin G synthesis by capillary isoelectric focusing immunoassay in oligoclonal band negative multiple sclerosis

Halbgebauer, S., Huss, A. M., Buttmann, M., Steinacker, P., Oeckl, P., Brecht, I., Weishaupt, A., Tumani, H., & Otto, M. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8094-3 · Cited by 17

Association of adverse childhood experiences with adulthood multiple sclerosis: A systematic review of observational studies

Rehan, S. T., Khan, Z., Shuja, S. H., Salman, A., Hussain, H. U., Abbasi, M. S., Razak, S., Cheema, H. A., Swed, S., & Surani, S. (2023) · Brain and Behavior · doi:10.1002/brb3.3024 · Cited by 17

Vanillic Acid Ameliorates Demyelination in a Cuprizone-Induced Multiple Sclerosis Rat Model: Possible Underlying Mechanisms

Safwat, S. M., Tohamy, M. E., Aboonq, M. S., Alrehaili, A., Assinnari, A., Bahashwan, A. S., ElGendy, A. A., & Hussein, A. M. (2023) · Brain Sciences · doi:10.3390/brainsci14010012 · Cited by 17

The Therapeutic Potential of Rho Kinase Inhibitor Fasudil Derivative FaD-1 in Experimental Autoimmune Encephalomyelitis

Zhao, Y., Zhang, X., Ding, Z., Yang, X., Zhang, H., Yu, J., Li, Y., Liu, C., Zhang, Q., Zhang, H., et al. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0411-7 · Cited by 15

Restriction spectrum imaging of white matter and its relation to neurological disability in multiple sclerosis

Sowa, P., Harbo, H. F., White, N. S., Celius, E. G., Bartsch, H., Berg‐Hansen, P., Moen, S. M., Bjørnerud, A., Westlye, L. T., Andreassen, O. A., et al. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458518765671 · Cited by 15

Investigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational study

Shirani, A., Zhao, Y., Karim, M. E., Petkau, J., Gustafson, P., Evans, C. D., Kingwell, E., van der Kop, M. L., Oger, J., & Tremlett, H. L. (2013) · European Journal of Neurology · doi:10.1111/ene.12324 · Cited by 14

Androstenediol Reduces Demyelination-Induced Axonopathy in the Rat Corpus Callosum: Impact on Microglial Polarization

Kalakh, S., & Mouihate, A. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00049 · Cited by 14

Comparison of Reported Spinal Cord Lesions in Progressive Multiple Sclerosis with Theiler’s Murine Encephalomyelitis Virus Induced Demyelinating Disease

Leitzen, E., Jin, W., Herder, V., Beineke, A., Elmarabet, S., Baumgärtner, W., & Hansmann, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040989 · Cited by 13

Magnetic resonance imaging perfusion is associated with disease severity and activity in multiple sclerosis

Sowa, P., Nygaard, G. O., Bjørnerud, A., Celius, E. G., Harbo, H. F., & Beyer, M. K. (2017) · Neuroradiology · doi:10.1007/s00234-017-1849-4 · Cited by 15

IL-27 plasma level in relapsing remitting multiple sclerosis subjects: The double-faced cytokine

Naderi, S., Hejazi, Z., Shajarian, M., Alsahebfosoul, F., Etemadifar, M., & Sedaghat, N. (2016) · Journal of Immunoassay and Immunochemistry · doi:10.1080/15321819.2016.1195746 · Cited by 14

Correction: The Detection of Surfactant Proteins A, B, C and D in the Human Brain and Their Regulation in Cerebral Infarction, Autoimmune Conditions and Infections of the CNS

Schob, S., Schicht, M., Sel, S., Stiller, D., Kekulé, A. S., Paulsen, F. P., Maronde, E., & Bräuer, L. (2013) · PLoS ONE · doi:10.1371/annotation/920eb90c-4f7f-4468-ae9c-1198b7b952fc · Cited by 14

Stem Cell Derived Extracellular Vesicle Therapy for Multiple Sclerosis, A Systematic Review and Meta-Analysis of Preclinical Studies

Barabadi, M., Paton, M. C. B., Kumar, N., Lim, R., & Payne, N. L. (2024) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szae011 · Cited by 13

Shuttling Tolerogenic Dendritic Cells across the Blood–Brain Barrier In Vitro via the Introduction of De Novo C–C Chemokine Receptor 5 Expression Using Messenger RNA Electroporation

Laere, M. D., Derdelinckx, J., Hassi, M., Kerosalo, M., Oravamäki, H., den Bergh, J. V., Berneman, Z. N., & Cools, N. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01964 · Cited by 13

Mice Heterozygous for the Sodium Channel Scn8a (Nav1.6) Have Reduced Inflammatory Responses During EAE and Following LPS Challenge

Alrashdi, B. M., Dawod, B., Tacke, S., Küerten, S., Côté, P. D., & Marshall, J. S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.533423 · Cited by 12

Immune response genes receptors expression and polymorphisms in relation to multiple sclerosis susceptibility and response to INF‐β therapy

Karam, R. A., Rezk, N. A., Amer, M. M., & Fathy, H. A. (2016) · IUBMB Life · doi:10.1002/iub.1530 · Cited by 12

Measurement of the permeability, perfusion, and histogram characteristics in relapsing-remitting multiple sclerosis using dynamic contrast-enhanced MRI with extended Tofts linear model

Li, Y., Yin, P., Xiong, H., Liu, Y., Sah, S. K., Zeng, C., Wang, J., & Hong, N. (2018) · Neurology India · doi:10.4103/0028-3886.232324 · Cited by 12

Global N-acetylaspartate concentration in benign and non-benign multiple sclerosis patients of long disease duration

Achtnichts, L., Gonen, O., Rigotti, D. J., Babb, J. S., Naegelin, Y., Penner, I., Bendfeldt, K., Hirsch, J. G., Amann, M., Kappos, L., et al. (2013) · European Journal of Radiology · doi:10.1016/j.ejrad.2013.08.037 · Cited by 12

Multimodal magnetic resonance imaging quantification of gray matter alterations in relapsing‐remitting multiple sclerosis and neuromyelitis optica spectrum disorder

Andica, C., Hagiwara, A., Yokoyama, K., Kato, S., Uchida, W., Nishimura, Y., Fujita, S., Kamagata, K., Hori, M., Tomizawa, Y., et al. (2022) · Journal of Neuroscience Research · doi:10.1002/jnr.25035 · Cited by 11

Pyroptosis the Emerging Link Between Gut Microbiota and Multiple Sclerosis

Fan, H., Shen, R., Yan, J., Bai, Y., Fu, Q., Shi, X., Du, G., & Wang, D. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s489454 · Cited by 12

Remyelination and the gut−brain axis

Duncan, I. D., & Watters, J. J. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1918897116 · Cited by 15

Future activity prediction of multiple sclerosis with 3D MRI using 3D discrete wavelet transform

Acar, Z. Y., Başçi̇ftçi̇, F., & Ekmekci, A. H. (2022) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2022.103940 · Cited by 11

A NOTCH4 missense mutation confers resistance to multiple sclerosis in Japanese

Huang, J., Yoshimura, S., Isobe, N., Matsushita, T., Yonekawa, T., Sato, S., Yamasaki, R., Kira, J., Miyamoto, K., Kusunoki, S., et al. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513482512 · Cited by 11

Roads to Formation of Normal Myelin Structure and Pathological Myelin Structure

Bandô, Y. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9636-7_16 · Cited by 12

Does M1 anodal transcranial direct current stimulation affects online and offline motor learning in patients with multiple sclerosis?

Masoudian, N., Ehsani, F., Nazari, M., Zoghi, M., & Jaberzadeh, S. J. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04359-9 · Cited by 11

The role of fibronectin in multiple sclerosis and the effect of drug delivery across the blood-brain barrier

Wei, S., Chen, L., Yang, F.-Y., Yang, F., & Wang, S. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.369102 · Cited by 11

The features of cerebral permeability and perfusion detected by dynamic contrast-enhanced magnetic resonance imaging with Patlak model in relapsing–remitting multiple sclerosis

Xiong, H., Yin, P., Li, X.-J., Yang, C., Zhang, D., Huang, X.-L., & Tang, Z.-Y. (2019) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s189598 · Cited by 10

Newly Identified Deficiencies in the Multiple Sclerosis Central Nervous System and Their Impact on the Remyelination Failure

Scalabrino, G. (2022) · Biomedicines · doi:10.3390/biomedicines10040815 · Cited by 10

Edaravone Inhibits the Production of Reactive Oxygen Species in Phagocytosis- and PKC-Stimulated Granulocytes from Multiple Sclerosis Patients Edaravone Modulate Oxidative Stress in Multiple Sclerosis

Villar-Delfino, P. H., Gomes, N. A., Christo, P. P., Nogueira-Machado, J. A., & Volpe, C. M. O. (2022) · Journal of Central Nervous System Disease · doi:10.1177/11795735221092524 · Cited by 10

Pathways to Progressive Disability in Multiple Sclerosis: The Role of Glial Cells in Chronic CNS Inflammation

Siffrin, V. (2025) · Glia · doi:10.1002/glia.70044 · Cited by 10

Effects Mediated by Dimethyl Fumarate on In Vitro Oligodendrocytes: Implications in Multiple Sclerosis

Guerriero, C., Puliatti, G., Marino, T. D., & Tata, A. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073615 · Cited by 9

Individual Differences in the Patient Experience of Relapsing Multiple Sclerosis (RMS): A Multi-Country Qualitative Exploration of Drivers of Treatment Preferences Among People Living with RMS

Tatlock, S., Sully, K., Batish, A., Finbow, C., Neill, W., Lines, C., Brennan, R., Adlard, N., & Backhouse, T. (2023) · Patient · doi:10.1007/s40271-023-00617-y · Cited by 9

Pharmacodynamic Consequences of Administration of VLA-4 Antagonist CDP323 to Multiple Sclerosis Subjects: A Randomized, Double-Blind Phase 1/2 Study

Wolf, C., Sidhu, J. S., Otoul, C., Morris, D. L., Cnops, J., Täubel, J., & Bennett, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058438 · Cited by 9

Measures of adiposity differentially correlate with C-reactive protein among persons with multiple sclerosis

Baynard, T., Hilgenkamp, T. I. M., Schroeder, E. C., Motl, R. W., & Fernhall, B. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.07.010 · Cited by 9

Antioxidant effects of resveratrol in granulocytes from multiple sclerosis patients

Villar-Delfino, P. H., Santos, R. P., Christo, P. P., Nogueira‐Machado, J. A., & Volpe, C. M. O. (2024) · Exploration of neuroscience · doi:10.37349/en.2024.00055 · Cited by 8

A Morphological and Behavioral Study of Demyelination and Remyelination in the Cuprizone Model: Insights into APLNR and NG2+ Cell Dynamics

Landzhov, B. V., Gaydarski, L., Stanchev, S., Kostadinova, I., Iliev, A. A., Kotov, G. N., Rashev, P., Mourdjeva, M., Pupaki, D. V., & Stamenov, N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313011 · Cited by 8

Red blood cells in type 1 diabetes and multiple sclerosis and technologies to measure their emerging roles

Geiger, M. K., Hayter, E., Martin, R. S., & Spence, D. M. (2022) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2022.100161 · Cited by 7

Comparing the effects of cerebellar and prefrontal anodal transcranial direct current stimulation concurrent with postural training on balance and fatigue in patients with multiple sclerosis: a double-blind, randomized, sham-controlled trial

Akbari, N. J., Tahan, N., Naimi, S. S., Baghban, A. A., Moghadam, N. B., & Zoghi, M. (2024) · Experimental Brain Research · doi:10.1007/s00221-024-06816-9 · Cited by 7

Temporal trends of incidence and prevalence of multiple sclerosis in Razavi Khorasan Province, Northeast Iran

Sarmadi, M., Saravani, H., Azizi, O., Najafi, F., Hadei, M., Momeni, J., & Bazrafshan, E. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05280-5 · Cited by 7

Promising Emerging Therapies for Multiple Sclerosis

Giovannoni, G. (2011) · Neurologic Clinics · doi:10.1016/j.ncl.2011.01.003 · Cited by 7

Stability of cognitive functions under mitoxantrone therapy in patients with progressive multiple sclerosis: A pilot analysis

Schröder, A., Klotz, P., Lee, D.-H., Gold, R., & Linker, R. A. (2011) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2011.02.018 · Cited by 7

Modeling the Chronic Loss of Optic Nerve Axons and the Effects on the Retinal Nerve Fiber Layer Structure in Primary Disorder of Myelin

Teixeira, L. B. C., Hoeve, J. N. V., Mayer, J. A., Dubielzig, R. R., Smith, C. M., Radcliff, A. B., & Duncan, I. D. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-19871 · Cited by 7

Steroid inhibition of erythrocyte-derived ATP reduces endothelial cell production of nitric oxide in a 3D-printed fluidic model

Janes, T., & Spence, D. M. (2018) · Analytical Methods · doi:10.1039/c8ay00870a · Cited by 7

Feline irradiated diet-induced demyelination; a model of the neuropathology of sub-acute combined degeneration?

Radcliff, A. B., Heidari, M., Field, A. S., & Duncan, I. D. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228109 · Cited by 7

From Multiple Sclerosis to Organ-Specific Autoimmune Disorders: Insights into the Molecular and Clinical Implications of Comorbidity

Zabihi, M. R., Zangooie, A., Piroozkhah, M., Harirchian, M. H., & Salehi, Z. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04458-0 · Cited by 6

New Insight into the Possible Roles of L-Carnitine in a Rat Model of Multiple Sclerosis

Safwat, S. M., Aboonq, M. S., Tohamy, M. E., Mojaddidi, M. A., Alqahtani, S. A. M., Zakari, M. O., ElGendy, A. A., & Hussein, A. M. (2023) · Brain Sciences · doi:10.3390/brainsci14010023 · Cited by 6

Association of HLA-DRA and IL2RA Polymorphisms with the Severity and Relapses Rate of Multiple Sclerosis in an Iranian Population

Asouri, M., Rokni, H. A., Sahraian, M. A., Fattahi, S., Motamed, N., Doosti, R., Amirbozorgi, G., Karimpoor, M., Mahboudi, F., & Akhavan‐Niaki, H. (2020) · Reports of Biochemistry and Molecular Biology · doi:10.29252/rbmb.9.2.129 · Cited by 6

Nitrosative stress parameters and the level of oxidized DNA bases in patients with multiple sclerosis

Borisovs, V., Bodrenko, J., Kalniņa, J., & Sjakste, N. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00786-5 · Cited by 5

A Review on the Feasibility and Efficacy of Home-Based Cognitive Remediation in People with Multiple Sclerosis

Boschetti, A., Maida, E., Dini, M., Tacchini, M., Gamberini, G., Comi, G., & Leocani, L. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13071916 · Cited by 5

No association of AQP4 polymorphisms with neuromyelitis optica and multiple sclerosis

Yang, T., He, Y., Xiang, Y., Ao, D., Wang, Y., Zhang, Q., He, X., Zhong, S., Wu, J., & Liu, G.-Z. (2016) · Translational Neuroscience · doi:10.1515/tnsci-2016-0012 · Cited by 5

The Endocannabinoid System and Human Brain Functions

Ashton, J. C., Dowie, M. J., & Glass, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809666-6.00005-8 · Cited by 7

Medroxyprogesterone acetate attenuates demyelination, modulating microglia activation, in a cuprizone neurotoxic demyelinating mouse model.

Mohammadi, M., Abdi, M., Alidadi, M., Mohamed, W. M. Y., Zibara, K., & Kashani, I. R. (2021) · PubMed Central · Cited by 5

Vitamin D deficiency in relation with the systemic and central inflammation during multiple sclerosis

Feki, S., Naifar, M., Dammak, M., Majdoub, S., Sakka, S., Ben, A., Hachicha, H., Mhiri, C., Ayadi, F. M., & Masmoudi, H. (2022) · Journal of Medical Biochemistry · doi:10.5937/jomb0-37676 · Cited by 5

Therapeutic Plasma Exchange and Multiple Sclerosis Dysregulations: Focus on the Removal of Pathogenic Circulatory Factors and Altering Nerve Growth Factor and Sphingosine-1-Phosphate Plasma Levels

Tonev, D. G., & Momchilova, A. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45100489 · Cited by 7

Cholesterol: A necessary evil from a multiple sclerosis perspective

Chandra, A., & Xu, Y. M. (2016) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12289 · Cited by 5

Pathological and protective effects of tumor necrosis factor-alpha in multiple sclerosis

Смагина, И. В., Elchaninova, S. A., Palashchenko, A. S., & Галактионова, Л. П. (2019) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro201911910214 · Cited by 4

Microglia specific alternative splicing alterations in multiple sclerosis

Qi, C., Ren, H., & Fan, Y. (2024) · Aging · doi:10.18632/aging.206045 · Cited by 5

Elevated ITGAX/CD11c in CSF-Derived Extracellular Vesicles Reflects Disability Progression in Multiple Sclerosis

Iwahara, N., Muraoka, S., Saito, T., Hirano, M., Yokokawa, K., Tanemoto, M., Oda, R., Nonaka, T., Suzuki, S., Adachi, J., et al. (2025) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200442 · Cited by 4

Evaluation of matrix metalloproteinase-9 plasma levels in untreated new Relapsing–remitting multiple sclerosis patients and their first-degree family

Samangooei, M., Farjam, M., Niknam, Z., Etemadifar, M., Meshkibaf, M. H., & Noroozi, S. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00758-9 · Cited by 4

Multiple sclerosis

Kiran, G. U., Priya, T. S., Kumari, P. K., Pradeepa, S. G. S., & Lavanya, S. (2024) · GSC Biological and Pharmaceutical Sciences · doi:10.30574/gscbps.2024.26.2.0378

Multiple Sclerosis Pathology

Lassmann, H. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a028936 · Cited by 937

What drives disease in multiple sclerosis: Inflammation or neurodegeneration?

Lassmann, H. (2010) · Clinical and Experimental Neuroimmunology · doi:10.1111/j.1759-1961.2009.00003.x · Cited by 50

Inflammation and degeneration in multiple sclerosis

Brück, W., & Stadelmann, C. (2003) · Neurological Sciences · doi:10.1007/s10072-003-0170-7 · Cited by 130

The relation between inflammation and neurodegeneration in multiple sclerosis brains

Frischer, J. M., Bramow, S., Dal-Bianco, A., Lucchinetti, C. F., Rauschka, H., Schmidbauer, M., Laursen, H., Sorensen, P. S., & Lassmann, H. (2009) · Brain · doi:10.1093/brain/awp070 · Cited by 1,450